Navigation Links
New Medical Device Relieves Carpal Tunnel Syndrome Without Surgery or Drugs
Date:7/12/2017

LOS ANGELES, July 12, 2017 /PRNewswire/ -- CarpalAID is a revolutionary new product that relieves painful carpal tunnel syndrome symptoms without drugs, braces or surgery.

Carpal tunnel syndrome affects more than 8 million people a year. Women suffer from carpal tunnel syndrome at twice the rate of men. The common methods of treating CTS are painful surgery, the use of NSAIDs or steroids, or mobilization with uncomfortable hand braces or gloves.

CarpalAID is a clear patch worn on the palm of the hand. It relieves pressure on the median nerve, and therefore the painful symptoms of carpal tunnel syndrome.
CarpalAID is a clear patch worn on the palm of the hand. It relieves pressure on the median nerve, and therefore the painful symptoms of carpal tunnel syndrome.

Now there is a surgery- and drug-free way to relieve the tingling, numbness, and pain caused by carpal tunnel syndrome.

CarpalAID, which is registered with the FDA, is a clear patch worn on the palm of the hand. It lifts the pressure off the median nerve and relieves pain within 10 to 20 minutes. Clinical trials of CarpalAID resulted in 70% positive outcomes.

Longtime engineer and CarpalAID inventor Joseph Nazari suffers from CTS on both hands. After having surgery on one hand, he sought another way to relieve the debilitating pain. Mr. Nazari tested various methods, including gluing a piece of cardboard to his hand and pulling on it. This immediately released the pressure on the median nerve — and relieved the pain.

After more studying and testing, the final result was CarpalAID.

"I used the prototype every night or every other night and pretty soon I didn't have the problem," Mr. Nazari said. "Today, two years later, I use the actual CarpalAID patch maybe once or twice a month."

CarpalAID, which is made in the U.S., will soon be available at pharmacies nationwide.

Carpal tunnel syndrome affects people from all walks of life including office workers, cooks, contractors, dentists, hair stylists, pregnant women, diabetics, weightlifters, and more.

More information about CarpalAID can be found online at CarpalAID.com. A video about how CarpalAID works can be viewed here. Watch testimonials about CarpalAID here.

Samples of the product are available upon request. Mr. Nazari, a resident of Glendale, CA, is also available for interviews.

Media Contact: Laura Tate
CJS Media
Phone: 323-205-6436
Email: laura@crackerjackscribe.com

Related Images

image1.jpg

image2.png

image3.jpg

image4.jpg

Related Links

CarpalAID Inventor Joseph Nazari

CarpalAID FAQs

Related Video

http://www.youtube.com/watch?v=T7vviJNZ9IE

View original content with multimedia:http://www.prnewswire.com/news-releases/new-medical-device-relieves-carpal-tunnel-syndrome-without-surgery-or-drugs-300486870.html


'/>"/>
SOURCE Carpal Aid, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. US Medical Equipment & Supply Demand to Reach $129 Billion in 2021
2. ivWatch Wins Top Honors at 2017 Medical Design Excellence Awards
3. City of Fremont, Biomedical Manufacturing Network and BSMA to Collaborate to Advance the Bio-Pharma Industry in California
4. AirXpanders Announces AeroForm Now Available in More than 100 Medical Institutions and Health Systems in the U.S.
5. Cressey & Company Makes Growth-Focused Investment in StatLab Medical Products
6. Getting Radiology Images to Patients Should Not Be Difficult or Expensive, Says Nautilus Medical
7. OBP Medical Launches Expanded Portfolio of Single-Use Lighted Specula at ACOG 2017
8. Natvar launches tight-tolerance, thermoplastic microextrusion medical tubing product line for demanding neurovascular, surgical applications
9. HD 4K 8MP Cath Lab Display Monitor LCD/LED Screens See Superior Advancement in Medical Technology - Ampronix
10. Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development
11. CRH Medical Corporation To Present at the Bloom Burton & Co. Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... ... of the Best Places to Work in the Research Triangle for 2017. , ... nominated, a company had to meet a threshold in employee participation--a percentage that ...
(Date:9/20/2017)... ... 2017 , ... Demand generation pioneer True Influence has announced ... The Marketing Tech Conference October 2–4, at the Hynes Convention Center in Boston, ... representing such thought-leading companies as JP Morgan Chase, GE Digital, and Dun & ...
(Date:9/20/2017)... ... ... In just a short time since going on sale on Wal-Mart Stores-owned ... trying the product for the first time, and others who had already been using ... Moore, MD, for everyone from athletes at risk from multiple concussions to elderly consumers ...
(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute (HSI) ... HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, 2017 to assist ... offering these discounted prices to all businesses and government agencies – whether or not ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm ... Friday, September 8, and Monday, September 11, off work and rolled up their sleeves ... before heading to local homes to start the process of rebuilding. , CORDA founder ...
Breaking Medicine News(10 mins):